The DNA testing market in Mexico reached USD 146.9 million in 2025. Looking ahead, IMARC Group expects the market to reach USD 277.2 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 7.10% during 2026-2034 . The market is driven by several factors, including technological advancements in genomics, improved public awareness of genetic health risks and ancestry, the increasing adoption of direct-to-consumer (DTC) testing kits, the integration of artificial intelligence (AI) into data analysis, and government support for personalized healthcare. All of these factors combined are fueling the growth of the DNA testing market share in Mexico.
|
Report attribute
|
Key statistics
|
|---|---|
|
Base year
|
2025 |
|
Projected years
|
2026-2034
|
|
Historical years
|
2020-2025
|
| Market size in 2025 | USD 146.9 million |
| Market forecast in 2034 | USD 277.2 million |
| Market growth rate 2026-2034 | 7.10% |
Integration of artificial intelligence in genetic diagnosis
Thanks to improvements in the analysis and interpretation of complex genetic information, artificial intelligence (AI) is revolutionizing the Mexican DNA testing sector. AI algorithms can efficiently process large datasets, identifying correlations and patterns that may be missed by traditional methods. This integration enables earlier diagnosis of genetic conditions, personalized treatment protocols, and more accurate diagnoses. AI in genetic diagnostics not only improves clinical outcomes but also streamlines laboratory operations, making genetic testing more affordable and accessible. The growing applications of AI technology in genetic diagnostics are expected to drive the expansion of the DNA testing market in Mexico. For example, as reported in industry publications, scientists have created an AI-based smart PCR system with significantly improved DNA amplification, particularly for damaged forensic samples. Thanks to machine learning, the system adapts the PCR conditions to each sample, increasing success rates and minimizing errors. This technology is poised to revolutionize forensic science, clinical diagnosis, and environmental monitoring by increasing sensitivity and effectiveness.
Government initiatives to promote genomic medicine
The integration of genomic medicine into the Mexican healthcare system has the active support of the government. Organizations such as the National Institute of Genomic Medicine (INMEGEN) are leading research and development in fields such as pharmacogenomics, nutrigenomics, and oncogenomics. Through the use of personalized medicine techniques, these programs aim to improve disease prevention, diagnosis, and treatment. The government is creating a favorable environment for the expansion of the DNA testing industry by funding genomic research and infrastructure. This support improves healthcare outcomes and advances scientific understanding, which in turn drives the growth of the DNA testing market in Mexico. For example, in October 2023, the Mexican Biobank, developed through a collaboration between Mexican and international institutions, launched the most comprehensive genetic database in Mexico. Covering all 32 states and analyzing more than 1.8 million genetic markers from 6,000 individuals, it highlights regional ancestry and diversity. This landmark project supports equitable genomic medicine worldwide.
IMARC Group offers an analysis of key trends in each market segment, along with country/regional forecasts for 2026-2034. Our report has categorized the market based on product type, technology, and application.
-1-3.webp)
Product Types Insights:
The report offers a detailed breakdown and analysis of the market based on product type. This includes equipment (DNA analyzers, PCR (polymerase chain reaction) machines, sequencers, electrophoresis systems, and others), consumables (reagents and kits and PCR consumables (primers, probes, DNA extraction kits, sample collection devices, and others)), software (data analysis software, laboratory information management systems (LIMS), genetic analysis software, bioinformatics software, and others), and services (testing services (genetic testing, forensic testing, and others), data interpretation services, consultation services (genetic counseling), laboratory services (sample processing and DNA sequencing services), and others).
Technology insights:
The report also provides a detailed breakdown and analysis of the market based on technology. This includes DNA diagnostics based on polymerase chain reaction (PCR), in situ hybridization, microarray, and next-generation sequencing (NGS).
Application Insights:
The report also provides a detailed breakdown and analysis of the market by application. This includes newborn DNA screening, prenatal DNA carrier screening, cancer diagnostics and histopathology, preimplantation genetic testing, infectious disease diagnosis, pharmacogenomic diagnostic testing, identity and forensic diagnostics, and others.
Regional Insights:
El informe también ha proporcionado un análisis exhaustivo de los principales mercados regionales, que incluyen el norte de México, el centro de México, el sur de México y otros.
El informe de investigación de mercado también ha proporcionado un análisis exhaustivo del panorama competitivo. El informe incluye análisis de la competencia como la estructura del mercado, el posicionamiento de los actores clave, las principales estrategias ganadoras, el cuadro de mando de la competencia y el cuadrante de evaluación de las empresas. También se ofrecen perfiles detallados de las principales empresas.
| Características del informe | Detalles |
|---|---|
| Año base del análisis | 2025 |
| Período histórico | 2020-2025 |
| Periodo de previsión | 2026-2034 |
| Unidades | Millones USD |
| Alcance del informe |
Análisis de tendencias históricas y perspectivas de mercado, catalizadores y retos del sector, evaluación histórica y futura del mercado por segmentos:
|
| Tipos de productos cubiertos |
|
| Tecnologías cubiertas | Reacción en cadena de la polimerasa (PCR), hibridación in situ, micromatrices, secuenciación de próxima generación (NGS) Diagnóstico del ADN |
| Aplicaciones cubiertas | Detección de ADN en recién nacidos, Detección prenatal de portadores de ADN, Diagnóstico oncológico e histopatológico, Diagnóstico preimplantacional, Diagnóstico de enfermedades infecciosas, Pruebas de diagnóstico farmacogenómico, Diagnóstico de identidad y forense, Otros |
| Regiones Cubiertas | Norte de México, Centro de México, Sur de México, Otros |
| Ámbito de personalización | 10% Personalización gratuita |
| Apoyo de analistas postventa | 10-12 semanas |
| Formato de entrega | PDF y Excel por correo electrónico (también podemos proporcionar la versión editable del informe en formato PPT/Word a petición especial) |
Key questions answered in this report:
Main benefits for stakeholders: